Expression of CD47 in Endometrial Cancer and Its Clinicopathological Significance

Table 5

CD47 expression in endometrial cancer with different clinicopathological variables.

Features		Cases	Positive cases	Positive rate (%)	Strong positive cases	Strong positive rate (%)	P value (positive)	P value (strong positive)
EC types	I	321	244	76.01	106	33.02	0.315	0.362
	II	23	15	65.22	10	43.48
Histological type	Endometrial adenocarcinoma	321	244	76.01	106	33.02	0.335	0.46
	Serous carcinoma	14	10	71.43	7	50.00
	Clear cell carcinoma	9	5	55.56	3	33.33
Infiltration depth	<1/2 muscle layer	270	197	72.96	62	22.96	0.068	<0.01
	>1/2 muscle layer	74	62	83.78	36	48.65
Clinical stage	I	247	171	69.23	51	20.65	<0.01	<0.01
	II	62	58	93.55	39	62.90
	III + IV	35	30	85.71	26	74.29
Histological grade	G1	190	146	76.84	60	31.58	0.714	0.265
	G2	96	71	73.96	31	32.29
	G3	58	42	72.41	25	43.10
Lymph node metastasis	No	184	134	72.83	50	27.17	0.406	<0.01
	Yes	31	26	83.87	20	64.51
	No lymph node cleaning	129	99	76.74	46	35.66
P53	Mutant	79	49	62.03	24	30.38	0.03	0.501
	Wild type	265	210	79.25	92	34.72
Ki67 proliferation index	>50%	76	56	73.68	27	35.53	0.763	0.784
	<50%	268	203	75.75	89	33.20